Hartalega stays anchored by long-term strategy, says CEO
"Ongoing uncertainty surrounding US tariff policies continues to weigh down on demand, especially in the US market, while also prompting a shift in long-term sourcing strategies among US importers," he added in his review of the company's first-quarter (1QFY26) results.
According to Kuan, the company's 1QFY26 performance reflects the ongoing recalibration taking place in the global sector.
Hartalega posted a net profit of RM12.61mil in the quarter under review, a sharp decline from RM31.93mil in the year-ago quarter for an earnings per share of 0.37 sen against 0.94 sen in the comparative quarter.
It said revenue was lower at RM553.11mil in 1QFY26 as compared to RM583.84mil in 1QFY25.
The group said the performance was impacted by a reduction in average selling prices (ASP) as well as lower sales volume, primarily owing to front-loaded inventories held by US customers and deferred orders in response to ongoing tariff developments.
At the same time, pricing pressures intensified in non-US markets, driven by excess supply from Chinese manufacturers.
In addition, operating profit was affected by the lower ASPs, strengthening of the ringgit and less favourable cost absorption resulting from lower capacity utilisation.
Kuan said Hartalega was anchored by its long-term strategy, focusing on enhancing production efficiency and cost optimisation, investing in advanced automation, maintaining robust fiscal discipline, and sharpening its sales approach to strengthen its competitiveness and resilience.
'While near-term conditions are challenging, structural glove demand for rubber gloves continues to hold strong prospects, driven by growing global healthcare needs and hygiene awareness.
"Our focus remains on building long-term value while continuing to uphold best practices in responsible manufacturing and ESG compliance."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
3 hours ago
- Free Malaysia Today
Glovemaker's subsidiary gets RM101mil additional tax bill
Hartalega Holdings Bhd said further announcements would be made as and when there are material developments. (File pic) KUALA LUMPUR : Hartalega Holdings Bhd's wholly-owned subsidiary, Hartalega NGC Sdn Bhd, has received a notice of additional assessment amounting to RM101.36 million from the Inland Revenue Board (LHDN) for the assessment years 2017 to 2022. In a filing with Bursa Malaysia, Hartalega said the notice received on Aug 4 involved additional tax assessments of RM13.92 million for 2017, RM36.35 million for 2018, RM10,695 for 2019, RM32.89 million for 2020, RM18.10 million for 2021 and RM90,625 for 2022. 'The company is currently seeking legal advice and evaluating its legal options, which may include initiating a formal appeal to the LHDN,' Hartalega said. It added that further announcements would be made as and when there are material developments.
The Sun
4 hours ago
- The Sun
Malaysia sets sights on becoming Asean pharmaceutical and healthcare hub
KUALA LUMPUR: Malaysia is setting its sights on becoming a halal pharmaceutical and healthcare hub for Asean, leveraging partnerships with India's booming pharma sector as industry leaders prepare for the Second Malaysia Pharma and Healthcare Expo (MPHC 2025) in October. The expo, to be held at the World Trade Centre Kuala Lumpur from Oct 7 to 9, is expected to attract over 100 companies, up from 70 last year, alongside policymakers, researchers and investors across Asean, India, Australia and South Korea. Organisers say the event will spotlight innovations in halal-certified drugs, active pharmaceutical ingredients (APIs), biotech, regenerative medicine, telehealth and AI-driven diagnostics. Malaysia-India Business Council general secretary Datuk Surendran Menon said trade between Malaysia and India stood at US$20 billion (RM84.6 billion) in 2024, but pharmaceuticals made up just US$96–$104 million of that figure, a sign of significant untapped potential. 'India is known as the pharma of the world, while Malaysia offers halal regulation expertise and a strategic Asean strong potential in contract manufacturing, technology transfer and joint R&D, especially in halal pharmaceuticals and vaccines,' Surendran told reporters at a media briefing today. He said Malaysia imports over 70% of its pharmaceutical products, and the government's national pharmaceutical policy is pushing for greater domestic production, a move that could entice Indian firms seeking to expand into Asean markets. He also pointed to India's own 200 million-strong Muslim population as an untapped market for halal pharma products manufactured in Malaysia. 'Even if we tap just 50 million of that halal market in India, it's far larger than our domestic market here. Halal-certified medicines made in Malaysia could be exported not just across Asean but also back into India itself,' he said. This strategy, he added, would allow two-way investment flows, Indian companies bringing R&D and cost efficiencies to Malaysia, while Malaysian firms could set up manufacturing or joint ventures in India. Asean-India Economic Council chairman Datuk Ramesh Kodammal said Malaysia stands to benefit from India's US$50 billion pharmaceutical export industry, particularly as Asean and India review their free trade agreement, which has been in place for 11 years. 'If we work closely with India, we will have a lot of benefit,' he said, adding Malaysia has a great advantage of re-exporting with these Indian companies for the Asean market a huge market of 700 million people. Ramesh confirmed 40 Indian companies are slated to participate in MPHC 2025, alongside Asean, Australian and South Korean firms.
The Sun
6 hours ago
- The Sun
Israel to partially reopen Gaza private goods trade amid aid crisis
JERUSALEM: Israel will partially reopen private sector trade with Gaza to reduce dependence on humanitarian aid, the defence ministry's civil affairs agency COGAT announced on Tuesday. The move follows months of blockade and conflict with Hamas, which has left Gaza in dire need of basic supplies. 'As part of formulating the mechanism, a limited number of local merchants were approved by the defence establishment, subject to several criteria and strict security screening,' COGAT said. Israel imposed a total blockade on Gaza in March but partially lifted restrictions in May to allow a US-backed private agency to distribute food. Despite resumed aid convoys and airdrops by Arab and European nations, UN experts warn famine is spreading in the war-torn enclave. The new trade mechanism will permit food staples, fruit, vegetables, baby formula, and hygiene products. Deliveries will undergo military inspections to prevent Hamas involvement, with payments made via monitored bank transfers. COGAT reported over 300 aid trucks entered Gaza on Monday, more than recent days, though Hamas disputed the figures, claiming only 95 trucks arrived, many looted amid alleged Israeli-instigated chaos. The UN estimates 500-600 daily truckloads are needed to sustain Gaza's population. - AFP
